BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 16793667)

  • 1. Antithrombotic map of the N-terminal domain of the GPIIIa subunit of the human platelet fibrinogen receptor (GPIIb-IIIa) determined in vivo by monoclonal, immunochemical inhibition of acute arterial thrombosis.
    Escudero C; Alvarez MV; de Haro J; Alvarez L; Millán I; Castillo-Olivares JL; González-Rodríguez J
    Platelets; 1997; 8(5):349-54. PubMed ID: 16793667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional characterization of GPIIb- and GPIIIa-specific monoclonal antibodies. Further evidence for the existence of agonist-specific activated states of the platelet fibrinogen receptor.
    de Castellarnau C; Cullaré C; Alvarez MV; Muñiz-Diez E; Calzada MJ; González-Rodríguez J
    Platelets; 1997; 8(4):243-53. PubMed ID: 16793655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa].
    Khaspekova SG; Vyzova TV; Lukin VV; Tikhomirov OIu; Berndt M; Kouns W; Mazurov AV
    Biokhimiia; 1996 Mar; 61(3):412-28. PubMed ID: 8724599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional characterization of PM6/13, a beta3-specific (GPIIIa/CD61) monoclonal antibody that shows preferential inhibition of fibrinogen binding over fibronectin binding to activated human platelets.
    Patel Y; Rahman S; Siddiqua A; Wilkinson JM; Kakkar VV; Authi KS
    Thromb Haemost; 1998 Jan; 79(1):177-85. PubMed ID: 9459345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial inhibition of platelet aggregation and fibrinogen binding by a murine monoclonal antibody to GPIIIa: requirement for antibody bivalency.
    Kutok JL; Coller BS
    Thromb Haemost; 1994 Dec; 72(6):964-72. PubMed ID: 7537915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further studies on the topography of the N-terminal region of human platelet glycoprotein IIIa. Localization of monoclonal antibody epitopes and the putative fibrinogen-binding sites.
    Calvete JJ; Arias J; Alvarez MV; Lopez MM; Henschen A; González-Rodríguez J
    Biochem J; 1991 Mar; 274 ( Pt 2)(Pt 2):457-63. PubMed ID: 1706596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the intimal hyperplasia in an arterial autograft model by blockade of the N-terminal of the integrin beta3 subunit by monoclonal antibody P37.
    Buján J; Bellón JM; Jurado F; García-Honduvilla N; Gimeno MJ; Escudero C; Alvarez MV; González-Rodríguez J
    Platelets; 1997; 8(5):337-47. PubMed ID: 16793666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a synthetic peptide corresponding to residues 313 to 320 of the alphaIIb subunit of the human platelet integrin alphaIIbbeta3 on carotid artery thrombosis in rabbits.
    Papamichael ND; Stathopoulou EM; Roussa VD; Tsironis LD; Kotsia AP; Stanica RM; Moussis V; Tsikaris V; Katsouras CS; Tselepis AD; Michalis LK
    J Pharmacol Exp Ther; 2009 May; 329(2):634-40. PubMed ID: 19244095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GPIIIa(90-102) and GPIIIa(631-653) epitopes as markers of conformational changes occurring during the activation of the glycoprotein IIb/IIIa complex.
    Niewiarowska J; Cierniewski CS
    Eur J Biochem; 1994 Sep; 224(3):803-9. PubMed ID: 7523118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allicin and disulfiram enhance platelet integrin alphaIIbbeta3-fibrinogen binding.
    Manaster Y; Shenkman B; Rosenberg N; Savion N
    Thromb Res; 2009 Sep; 124(4):477-82. PubMed ID: 19632706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of human fibrinogen receptor (GPIIb-IIIa) with decorsin.
    Yang J; Zhan CY; Dong XC; Yang K; Wang FX
    Acta Pharmacol Sin; 2004 Aug; 25(8):1096-104. PubMed ID: 15301746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting ligand-induced binding sites on GPIIb/IIIa via single-chain antibody allows effective anticoagulation without bleeding time prolongation.
    Stoll P; Bassler N; Hagemeyer CE; Eisenhardt SU; Chen YC; Schmidt R; Schwarz M; Ahrens I; Katagiri Y; Pannen B; Bode C; Peter K
    Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1206-12. PubMed ID: 17322097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of antibodies that bind GPIIb/IIIa: antagonist complexes.
    Breth L; Kochie J; Combs A; Wang S; Smallheer J; Billheimer J; Seiffert D; Hollis G; O'Neil K
    J Immunol Methods; 2005 Jun; 301(1-2):11-20. PubMed ID: 15992818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of platelet glycoprotein IIb-IIIa number and glycoprotein IIIa Leu33Pro polymorphism on platelet aggregation and sensitivity to glycoprotein IIb-IIIa antagonists.
    Sirotkina OV; Khaspekova SG; Zabotina AM; Shimanova YV; Mazurov AV
    Platelets; 2007 Nov; 18(7):506-14. PubMed ID: 17957566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteolytic dissection of the isolated platelet fibrinogen receptor, integrin GPIIb/IIIa. Localization of GPIIb and GPIIIa sequences putatively involved in the subunit interface and in intrasubunit and intrachain contacts.
    Calvete JJ; Mann K; Alvarez MV; López MM; González-Rodríguez J
    Biochem J; 1992 Mar; 282 ( Pt 2)(Pt 2):523-32. PubMed ID: 1546968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of arterial thrombosis by a monoclonal antibody against the 100 to 109 amino acid sequence stretch of the beta-subunit of the human platelet fibrinogen receptor: a comparative study with low dose aspirin.
    Escudero C; Alvarez L; de Haro J; González J; Alvarez MV; Millán I; Jorge-Herrero E; Castillo-Olivares JL
    J Am Coll Cardiol; 1994 Feb; 23(2):483-6. PubMed ID: 8294704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antiplatelet glycoprotein monoclonal antibodies: properties and practical value].
    Saffroy R; Bachelot C; Rendu F
    Ann Biol Clin (Paris); 1995; 53(3):97-105. PubMed ID: 7574103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of glycoprotein IIb/IIIa mediates the antithrombotic activity of butanol fraction of Actinostemma lobatum Maxim.
    Kim KH; Lee HJ; Lee JH; Jang YS; Kim DK; Shim BS; Cho KH; Ko SG; Ahn KS; Kim SH
    J Ethnopharmacol; 2008 Mar; 116(3):431-8. PubMed ID: 18243609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anti-platelet approach targeting the fibrinogen ligand of the GPIIB/IIIa receptor.
    Tsikaris V
    J Pept Sci; 2004 Oct; 10(10):589-602. PubMed ID: 15526708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AFM imaging of ligand binding to platelet integrin alphaIIbbeta3 receptors reconstituted into planar lipid bilayers.
    Hussain MA; Agnihotri A; Siedlecki CA
    Langmuir; 2005 Jul; 21(15):6979-86. PubMed ID: 16008412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.